Hormonal contraception in diabetic women: Acceptability and influence on diabetes control and ovarian function of a nonalkylated estrogen/progestogen compound-Reference-Cited by-同舟云学术

Hormonal contraception in diabetic women: Acceptability and influence on diabetes control and ovarian function of a nonalkylated estrogen/progestogen compound

Published:1985-07 Issue:1 Volume:32 Page:23-31
ISSN:0010-7824
Container-title:Contraception
language:en
Short-container-title:Contraception

Author:

Skouby Sven O.,Jensen Bente Møller,Kühl Claus,Mølsted-Pedersen Lars,Svenstrup Birgit,Nielsen Jan

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Reproductive Medicine

Reference19 articles.

1. The pregnant Diabetic and Her Newborn;Pedersen,1977

2. Congenital malformations: The possible role of diabetes care outside pregnancy;Pedersen,1979

3. Contraception in diabetic patients;Wiese;Acta Endocrinol Suppl. 182,1974

4. The effect of oral contraceptives on insulin requirements in diabetics;Steel;Br J Fam Plan,1978

5. Oral contraception in diabetic women. Diabetes control and high density lipoprotein lipids during low dosage progestogen, combined estrogen/progestogen and non-hormonal contraception;Rdberg;Acta Endocrinol,1981

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. U.S. Medical Eligibility Criteria for Contraceptive Use, 2024;MMWR. Recommendations and Reports;2024-08-08

2. U.S. Medical Eligibility Criteria for Contraceptive Use, 2016;MMWR. Recommendations and Reports;2016-07-29

3. Contraception in patients with medical conditions;Obstetrics, Gynaecology & Reproductive Medicine;2014-02

4. Contraception in patients with medical conditions;Obstetrics, Gynaecology & Reproductive Medicine;2011-09

5. Contraception for Women with Diabetes;Diabetes in Women;2009